ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 26 filers reported holding ACHILLES THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,326,750 | -3.7% | 2,557,149 | 0.0% | 0.01% | -7.1% |
| Q2 2023 | $2,417,017 | -2.6% | 2,557,149 | -1.3% | 0.01% | +7.7% |
| Q1 2023 | $2,481,233 | +6.4% | 2,591,366 | 0.0% | 0.01% | -7.1% |
| Q4 2022 | $2,332,229 | -60.2% | 2,591,366 | 0.0% | 0.01% | -63.2% |
| Q3 2022 | $5,856,000 | -10.3% | 2,591,366 | 0.0% | 0.04% | +2.7% |
| Q2 2022 | $6,530,000 | -14.3% | 2,591,366 | 0.0% | 0.04% | -15.9% |
| Q1 2022 | $7,619,000 | -41.3% | 2,591,366 | 0.0% | 0.04% | -30.2% |
| Q4 2021 | $12,983,000 | -35.7% | 2,591,366 | 0.0% | 0.06% | -29.2% |
| Q3 2021 | $20,187,000 | -20.4% | 2,591,366 | 0.0% | 0.09% | -19.8% |
| Q2 2021 | $25,369,000 | -40.8% | 2,591,366 | 0.0% | 0.11% | -40.3% |
| Q1 2021 | $42,887,000 | – | 2,591,366 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,014,687 | $49,094,000 | 0.79% |
| Boxer Capital, LLC | 1,536,016 | $15,038,000 | 0.53% |
| Artal Group S.A. | 2,255,375 | $22,080,000 | 0.45% |
| Redmile Group, LLC | 2,088,089 | $20,442,000 | 0.30% |
| Affinity Asset Advisors, LLC | 80,000 | $783,000 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 292,194 | $2,861,000 | 0.19% |
| Orbimed Advisors | 1,584,845 | $15,516,000 | 0.16% |
| Baker Brothers Advisors | 2,591,366 | $25,369,000 | 0.11% |
| Perceptive Advisors | 1,510,750 | $14,790,000 | 0.10% |
| Monashee Investment Management LLC | 64,697 | $633,000 | 0.08% |